Benign kidney tumors generally do not affect life expectancy, while the survival time of malignant tumors after surgery has individual differences. If patients can receive standardized treatment in the early stage of the disease, some patients can even achieve cure, which has little effect on life expectancy. Kidney tumors are divided into benign tumors and malignant tumors. Smaller benign kidney tumors can be reviewed regularly and do not require surgery. Larger benign tumors can be selected for tumor resection surgery or nephrectomy surgery, and the life expectancy of patients is generally not affected. And the prognosis of malignant tumor of kidney is related to the pathological type and clinical stage of the tumor, the higher the malignancy, the worse the prognosis. If active treatment is taken in time at the early stage of the disease, it has little effect on the life expectancy of patients. However, if the kidney tumor has metastasized, especially if there is excessive fear, negative treatment and failure to further control the progression of the disease, it will significantly affect the life expectancy of patients. Early treatment is extremely helpful to improve the prognosis of kidney tumor, so symptoms such as hematuria and kidney area mass should be treated promptly.